NCT01798134View on ClinicalTrials.gov

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

March 31, 2015

Conditions
Hepatocellular Carcinoma
Interventions
DEVICE

TANDEM™

Trial Locations (7)

45147

Universitatsklinikum Essen, Essen

64283

Kilinikum Darmstadt, Darmstadt

69120

Klinikum der Universitat Heidelberg, Heidelberg

70174

Klinikum Stuttgart- Katharinenhospital, Stuttgart

74078

SLK-Kliniken Heilbronn GmbH, Heilbronn

81925

Klinikum Bogenhausen, München

93042

University Hospital Regensburg, Regensburg

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY